MRK
56
5
AMP
78
2
ADM
36
-4
AAPL
55
2
MAC
75
-4
AAL
50
2
MNST
59
2
SHW
64
2
NWL
41
-6
LYB
39
-7
LRCX
64
6
BSX
73
2
SJM
36
-2
AFL
66
2
AN
61
-2
K
45
-3
GE
65
4
WDC
57
3
YUM
62
4
GME
88
-10
MRK
56
5
AMP
78
2
ADM
36
-4
AAPL
55
2
MAC
75
-4
AAL
50
2
MNST
59
2
SHW
64
2
NWL
41
-6
LYB
39
-7
LRCX
64
6
BSX
73
2
SJM
36
-2
AFL
66
2
AN
61
-2
K
45
-3
GE
65
4
WDC
57
3
YUM
62
4
GME
88
-10
Financhill
Back

Supernus Pharmaceuticals Vs. Dynavax Technologies Industry Stock Comparison

Sell
31

SUPN
Supernus Pharmaceuticals

Last Price:
29.25
Seasonality Move:
14.18%
Buy
56

DVAX
Dynavax Technologies

Last Price:
11.27
Seasonality Move:
18.27%
Sell
31
Supernus Pharmaceuticals (SUPN) is a Sell

Is Supernus Pharmaceuticals a Buy, Sell or Hold?

  • The current Supernus Pharmaceuticals [SUPN] share price is $28.74. The Score for SUPN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • SUPN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Dynavax Technologies (DVAX) is a Buy

Is Dynavax Technologies a Buy, Sell or Hold?

  • The current Dynavax Technologies [DVAX] share price is $11.04. The Score for DVAX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • DVAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SUPN Stock Price Chart

What is Supernus Pharmaceuticals's stock price today?

  • The Supernus Pharmaceuticals share price today is $28.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SUPN is experiencing selling pressure, which indicates risk of future bearish movement.

DVAX Stock Price Chart

What is Dynavax Technologies's stock price today?

  • The Dynavax Technologies share price today is $11.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DVAX is experiencing slight selling pressure.

SUPN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 39.72 Sell
Chaikin Money Flow: -306562 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.18 - 30.78) Sell
Bollinger Bands (100): (27.87 - 32.19) Sell

DVAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 38.81 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.14 - 11.8) Sell
Bollinger Bands (100): (11.65 - 13.61) Sell

SUPN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.91 Sell
20-day SMA: 29.94 Sell
50-day SMA: 31.56 Sell
200-day SMA: 29.07 Sell
8-day EMA: 29.58 Sell
20-day EMA: 30.1 Sell
50-day EMA: 30.5 Sell
200-day EMA: 30.2 Sell

DVAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.23 Sell
20-day SMA: 11.41 Sell
50-day SMA: 11.89 Sell
200-day SMA: 13.33 Sell
8-day EMA: 11.17 Sell
20-day EMA: 11.4 Sell
50-day EMA: 11.84 Sell
200-day EMA: 12.67 Sell

Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.33 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.19 per share, and an increase next year of $0.58 per share.

Dynavax Technologies Earnings Growth & DVAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.10 per share, an increase this year of $0.39 per share, and an increase next year of $0.39 per share.

Supernus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dynavax Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):